Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy

NCT03077217 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Changzheng Hospital